A Biobehavioral Intervention for Latino/Hispanic Young Adults With Cancer
- Disease/Condition
- Cancer
- Drug/Device/Intervention
- Goal-Focused Emotion-Regulation Therapy (GET)
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- University of California, Irvine
- Phase
- N/A
- Start date
- May 01, 2024
- End date
- Jun 01, 2026
- Enrollment
- 100 participants
Change in Hospital Anxiety and Depression Scale (HADS),Change in Systemic Pro-inflammatory Cytokine Levels (IL-6, IL-1ra, C-reactive Protein (CRP), sTNFαRII),Change in Salivary Diurnal Cortisol Daily Output
Building upon the results of a single-arm trial designed to investigate the feasibility and
 acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET), this
 trial is a randomized-controlled biobehavioral pilot trial of GET versus a time-and attention
 matched control (Instrumental Supportive Listening; ISL) in Latino/Hispanic young adult
 cancer survivors. Outcomes include improved distress symptoms, emotion regulation, goal
 navigation skills, and changes in stress-sensitive biomarkers.
 
 Participants will be randomized to receive six sessions of GET or ISL delivered over eight
 weeks. In addition to indicators of intervention feasibility, the investigators will measure
 primary and secondary psychological outcomes prior to (T0), immediately after (T1), and
 twelve weeks after intervention (T2). Additionally, identified biomarkers will be measured at
 baseline and at T1, and T2.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06338475
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06338475 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Irvine and is currently Not yet recruiting. The study focuses on Cancer. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.